Free Webinar
The Science Behind the
New Cannabinoids Coming to Market
Wednesday 26 January 2022
11h NYC time
West Coast USA 8h = Mexico City/Chicago 10h = East Coast USA 11h = London 16h = 17h Europe = Tel Aviv/South Africa 18h
= Singapore/HK/China/Perth 0h = Korea/Japan 1h = Melbourne 2h
About the Webinar
You might have heard a lot about TCH and CBD, but also coming to market will be CBDA, CBDV, CBC, CBG, and more! What do you need to know? Join Dr. Jamie Baumgartner, Director of Science and President of Panacea Life Sciences, a recognized expert in cannabinoids. He'll explain:
-
Why cannabinoids?
-
Regulatory issues
USA and International regulatory landscape; INCI names
-
Dermal cannabinoid effects
Including poly-pharmacology
-
What does the future hold?
-
About Dr. Baumgartner
Jamie holds a Bachelor of Science in Biochemistry from the UC, Davis and a Ph.D. in Biochemistry from Washington State University. He has worked with over 700 biotechnology and pharmaceutical companies in drug discovery and development.
Since conducting initial testing of CBD and THC on various preclinical models of pain, Jamie has devoted his efforts to develop and characterizing industrial hemp-based products for people in need of alternative medications. Currently, Jamie is focused on building a researc platform to evaluate caannabidiol and other cannabinoids for biological effects, developing collaborations with research institutions, and working with various government agencies to educate and influece policy relating to industrial hemp.
Dr. Jamie Baumgarnter
Presenter
Perry Romanowski, Guest Scientist and IFSCC Education Chair
Guest Scientist
Mary Lynn Halland, IFSCC Secretary General
Webinar Host